Antiplatelet aggregation and endothelial protection of I₄, a new synthetic anti-diabetes sulfonylurea compound

References

• Pasterkamp G. Methods of accelerated atherosclerosis in diabetic patients. Heart 2013;99:743–749
   PubMedGoogle Scholar
• Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes- related complications. Physical therapy 2008;88:1254–1264
   PubMed Web of Science ®Google Scholar
• Linden MD, Tran hours, Woods R, Tonkin A. High platelet reactivity and antiplatelet therapy resistance. Semin Thromb Hemost 2012;38:200–212
   PubMed Web of Science ®Google Scholar
• Schafer A, Bauersachs J. Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis. Curr Vasc Pharmacol 2008;6:52–60
   PubMed Web of Science ®Google Scholar
• Natarajan A, Zaman AG, Marshall SM. Platelet hyperactivity in type 2 diabetes: Role of antiplatelet agents. Diabetes & vascular disease research. Diab Vasc Dis Res 2008;5:138–144
   PubMed Web of Science ®Google Scholar
• Shi GF, Morrell CN. Platelets as initiators and mediators of inflammation at the vessel wall. Thromb Res 2011;127:387–390
   PubMed Web of Science ®Google Scholar
• Nacci C, Tarquinio M, Montagnani M. Molecular and clinical aspects of endothelial dysfunction in diabetes. Intern Emerg Med 2009;4:107–116
   PubMed Web of Science ®Google Scholar
• Fresno M, Diaz-Munoz MD, Cuesta N, Cacheiro-Llaguno C, Iniguez MA. Prostanoids actions in cardiovascular physiopathology. An Real Acad Nac F 2008;74:675–696
   Google Scholar
• van den Oever IAM, Raterman HG, Nurmohamed MT, Simsek S. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators Inflamm 2010:1–15
   Google Scholar
• Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058–1070
   PubMed Web of Science ®Google Scholar
• Nie hours, Wu JL, Zhang M, Xu J, Zou MH. Endothelial nitric oxide synthase-dependent tyrosine nitration of prostacyclin synthase in diabetes in vivo. Diabetes 2006;55:3133–3141
   PubMed Web of Science ®Google Scholar
• Glushakova O, Kosugi T, Roncal C, Mu W, Heinig M, Cirillo P, Sanchez-Lozada LG, Johnson RJ, Nakagawa T. Fructose induces the inflammatory molecule ICAM-1 in endothelial cells. J Am Soc Nephrol 2008;19:1712–1720
   PubMed Web of Science ®Google Scholar
• Wu GZ, Hong G, Zhang WP, Zhang HB. Effect of 1-[4-[2- (4-bromobenzenesulfonamino) ethyl] phenylsulfonyl]-3-(trans-4-methylcyclohexyl) urea (I4), a new synthetic sulfonylurea compound, on glucose metabolism in vivo and in vitro. Arzneimittel-Forschung 2009;59:550–556
   PubMedGoogle Scholar
• Dogne JM, de Leval X, Neven P, Rolin S, Wauters J, David JL, Delarge J, Massereel B. Effects of a novel non-carboxylic thromboxane A2 receptor antagonist (BM-531) derived from torasemide on platelet function. Prostaglandins Leukot Essent Fatty Acids 2000;62:311–317
   PubMed Web of Science ®Google Scholar
• Lu N, Zhan M, Gao C, Wu G, Zhang H. I4, a new synthetic sulfonylurea compound, inhibits the action of TXA2 in vivo and in vitro on platelets and aorta vascular smooth muscle. Thromb Res 2012;130:e209–e215
   PubMedGoogle Scholar
• Shi CG, Wang LM, Wu Y, Wang P, Gan ZJ, Lin K, Jiang LX, Xu ZQ, Fan M. Intranasal administration of nerve growth factor produces antidepressant-like effects in animals. Neurochem Res 2010;35:1302–e1314
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Moons L, Stassen JM, De Mol M, Bouche A, van den Oord JJ, Kockx M, Collen D. Vascular wound healing and neointima formation induced by perivascular electric injury in mice. Am J Pathol 1997;150:761–776
   PubMedGoogle Scholar
• Moller F, Tranholm M. A ferric chloride induced arterial injury model used as haemostatic effect model. Haemophilia 2010;16:216–222
   Web of Science ®Google Scholar
• Dogukan A, Sahin N, Tuzcu M, Juturu V, Orhan C, Onderci M, Komorowski J, Sahin K. The effects of Chromium histidinate on mineral status of serum and tissue in fat-fed and Streptozotocin-treated Type II diabetic rats. Biol Trace Elem Res 2009;131:124–132
   PubMed Web of Science ®Google Scholar
• Siller-Matula JM, Spiel AO, Lang IM, Kreiner G, Christ G, Jilma B. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am Heart J 2009;157:148 e141–145
   PubMed Web of Science ®Google Scholar
• Shahriyary L, Yazdanparast R. Inhibition of blood platelet adhesion, aggregation and secretion by Artemisia dracunculus leaves extracts. J Ethnopharmacol 2007;114:194–198
   PubMed Web of Science ®Google Scholar
• Eriksson AC, Whiss PA. Measurement of adhesion of human platelets in plasma to protein surfaces in microplates. J Pharmacol Toxicol Methods 2005;52:356–365
   PubMedGoogle Scholar
• Hapangama DK, Turner MA, Drury JA, Quenby S, Saretzki G, Martin-Ruiz C, Von Zglinicki T. Endometriosis is associated with aberrant endometrial expression of telomerase and increased telomere length. Hum Reprod 2008;23:1511–1519
   PubMed Web of Science ®Google Scholar
• Sobel BE, Taatjes DJ, Schneider DJ. Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2003;23:1979–1989
   PubMed Web of Science ®Google Scholar
• Ferroni P, Basili S, Falco A, Davi G. Platelet activation in type 2 diabetes mellitus. J Thromb Haemost 2004;2:1282–1291
   PubMed Web of Science ®Google Scholar
• Ferroni P, Martini F, Riondino S, La Farina F, Magnapera A, Ciatti F, Guadagni F. Soluble P-selectin as a marker of in vivo platelet activation. Clinica Chimica Acta 2009;399:88–91
   PubMed Web of Science ®Google Scholar
• Niccoli G, Giubilato S, Russo E, Spaziani C, Leo A, Porto I, Leone AM, Burzotta F, Riondino S, Pulcinelli F, et al. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention. Eur Heart J 2008;29:1843–1850
   PubMed Web of Science ®Google Scholar
• Reininger AJ. Function of von Willebrand factor in haemostasis and thrombosis. Haemophilia 2008;14:11–26
   PubMedGoogle Scholar
• Marx I, Christophe OD, Lenting PJ, Rupin A, Vallez MO, Verbeuren TJ, Denis CV. Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa. Blood 2008;112:603–609
   PubMed Web of Science ®Google Scholar
• van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukocyte Biol 2009;85:195–204
   PubMed Web of Science ®Google Scholar
• Triggle CR, Ding H. A review of endothelial dysfunction in diabetes: a focus on the contribution of a dysfunctional eNOS. J Am Soc Hypertens 2010;4:102–115
   PubMedGoogle Scholar
• Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J 2009;73:411–418
   PubMed Web of Science ®Google Scholar
• Rabbani SI, Devi K, Khanam S. Inhibitory effect of glimepiride on nicotinamide- streptozotocin induced nuclear damages and sperm abnormality in diabetic Wistar rats. Indian J Exp Biol 2009;47:804–810
   PubMedGoogle Scholar
• Papanas N, Tziakas D, Chalikias G, Floros D, Trypsianis G, Papadopoulou E, Kortsaris A, Symeonidis G, Souliou E, Maltezos E, Hatseras D. Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients. Diabetes Metab 2006;32: 344–349
   PubMedGoogle Scholar
• Ueba hours, Kuroki M, Hashimoto S, Umemoto T, Yasu T, Ishikawa S, Saito M, Kawakami M. Glimepiride induces nitric oxide production in human coronary artery endothelial cells via a PI3-kinase-Akt dependent pathway. Atherosclerosis 2005;183:35–39
   PubMedGoogle Scholar